Nonrulemaking

Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request

Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

No documents mirrored for this docket yet.

© 2026 Government Context · not affiliated with any U.S. government agencyPrivacyTermsDockets